Endogenously produced pro-oxidant reactive species are important to life, being concerned in a number of organic features. Nevertheless, when overproduced (e.g. attributable to exogenous stimulation), or when the degrees of antioxidants grow to be severely depleted, these reactive species grow to be extremely dangerous, inflicting oxidative stress by the oxidation of biomolecules, resulting in mobile harm which will grow to be irreversible and trigger cell dying.
The scientific analysis within the subject of reactive oxygen species (ROS) related organic features and/or deleterious results is repeatedly requiring new delicate and particular instruments with a purpose to allow a deeper perception on its motion mechanisms.
Nevertheless, reactive species current some traits that make them troublesome to detect, specifically their very brief lifetime and the number of antioxidants present in vivo, able to capturing these reactive species. It’s, subsequently, important to develop methodologies able to overcoming this kind of obstacles.
Fluorescent probes are wonderful sensors of ROS attributable to their excessive sensitivity, simplicity in knowledge assortment, and excessive spatial decision in microscopic imaging methods. Therefore, the principle aim of the current paper is to evaluate the fluorescence methodologies which were used for detecting ROS in organic and non-biological media.
Normalization of gene expression measurements in tumor tissues: comparability of 13 endogenous management genes.
For interpretation of quantitative gene expression measurements in medical tumor samples, a normalizer is important to right expression knowledge for variations in mobile enter, RNA high quality, and RT effectivity between samples. In lots of research, a single housekeeping gene is used for normalization. Nevertheless, no unequivocal single reference gene (with confirmed invariable expression between cells) has been recognized but.
As the most effective various, the imply expression of a number of housekeeping genes can be utilized for normalization. On this research, no try was made to find out the gold-standard gene for normalization, however to determine the most effective single housekeeping gene that would precisely substitute the measurement of a number of genes.
Expression patterns of 13 steadily used housekeeping genes had been decided in 80 regular and tumor samples from colorectal, breast, prostate, pores and skin, and bladder tissues with real-time quantitative RT-PCR. These genes included, giant ribosomal protein, beta-actin, cyclophilin A, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerokinase 1, beta-2-microglobin, beta-glucuronidase, hypoxanthine ribosyltransferase (HPRT), TATA-box-binding protein, transferrin receptor, porphobilinogen deaminase, ATP synthase 6, and 18S ribosomal RNA.
Principal element evaluation was used to research these expression patterns, unbiased of the extent of expression. Our method recognized HPRT as the one greatest reference gene that could possibly be used as an correct and financial various for the measurement of a number of housekeeping genes. We advocate this gene for future research to standardize gene expression measurements in most cancers analysis and tumor diagnostics till a particular gold customary has been decided.
Mapping intact protein isoforms in discovery mode utilizing top-down proteomics.
A full description of the human proteome depends on the difficult process of detecting mature and altering types of protein molecules within the physique. Massive-scale proteome evaluation has routinely concerned digesting intact proteins adopted by inferred protein identification utilizing mass spectrometry. This ‘bottom-up’ course of affords a excessive variety of identifications (not at all times distinctive to a single gene).
Nevertheless, issues come up from incomplete or ambiguous characterization of different splice kinds, numerous modifications (for instance, acetylation and methylation) and endogenous protein cleavages, particularly when mixtures of those create advanced patterns of intact protein isoforms and species.
‘High-down’ interrogation of complete proteins can overcome these issues for particular person proteins, however has not been achieved on a proteome scale owing to the dearth of intact protein fractionation strategies which are effectively built-in with tandem mass spectrometry.
Right here we present, utilizing a brand new four-dimensional separation system, identification of 1,043 gene merchandise from human cells which are dispersed into greater than 3,000 protein species created by post-translational modification (PTM), RNA splicing and proteolysis.
The general system produced larger than 20-fold will increase in each separation energy and proteome protection, enabling the identification of proteins as much as 105 kDa and people with as much as 11 transmembrane helices. Many beforehand undetected isoforms of endogenous human proteins had been mapped, together with adjustments in multiply modified species in response to accelerated mobile ageing (senescence) induced by DNA harm.
Built-in with the newest model of the Swiss-Prot knowledgebase, the knowledge present exact correlations to particular person genes and proof-of-concept for large-scale interrogation of complete protein molecules. The know-how guarantees to enhance the hyperlink between proteomics knowledge and sophisticated phenotypes in fundamental biology and illness analysis.
Remedy-induced senescence in most cancers.
Mobile senescence is a response to nonlethal stress that ends in persistent cytostasis with a definite morphological and biochemical phenotype. The senescence phenotype, detected in tumors by the expression of mRNA and protein markers, could be generated in most cancers cells missing practical p53 and retinoblastoma protein. Present analysis means that therapy-induced senescence (TIS) represents a novel practical goal which will enhance most cancers remedy.
TIS could be induced in immortal and reworked most cancers cells by chosen anticancer compounds or radiation, and accumulating knowledge point out that TIS could produce diminished toxicity-related unwanted effects and elevated tumor-specific immune exercise.
This evaluate examines the present standing of TIS-regulated mechanisms, brokers, and senescence biomarkers with the aim of encouraging additional growth of this method to most cancers remedy. Remaining hurdles embody the dearth of environment friendly senescence-inducing brokers and incomplete organic knowledge on tumor response. The identification of further compounds and different focused approaches to senescence induction will additional the event of TIS within the medical remedy of most cancers.
The neurobiology and management of anxious states.
Concern is an adaptive element of the acute “stress” response to potentially-dangerous (exterior and inner) stimuli which threaten to perturb homeostasis. Nevertheless, when disproportional in depth, power and/or irreversible, or not related to any real threat, it could be symptomatic of a debilitating anxious state: for instance, social phobia, panic assaults or generalized nervousness dysfunction.
In view of the significance of guaranteeing an acceptable emotional response to aversive occasions, it isn’t shocking {that a} variety of mechanisms are concerned within the induction and inhibition of anxious states. Other than standard neurotransmitters, corresponding to monoamines, gamma-amino-butyric acid (GABA) and glutamate, many different modulators have been implicated, together with: adenosine, cannabinoids, quite a few neuropeptides, hormones, neurotrophins, cytokines and a number of other mobile mediators.
Accordingly, although benzodiazepines (which reinforce transmission at GABA(A) receptors), serotonin (5-HT)(1A) receptor agonists and 5-HT reuptake inhibitors are presently the precept medication employed within the administration of hysteria issues, there may be appreciable scope for the event of different therapies.
Along with mobile, anatomical and neurochemical methods, behavioral fashions are indispensable for the characterization of anxious states and their modulation. Amongst numerous paradigms, battle procedures–in which topics expertise opposing impulses of need and fear–are of especial conceptual and therapeutic pertinence.
For instance, within the Vogel Battle Check (VCT), the power of medicine to launch punishment-suppressed consuming conduct is evaluated. In reviewing the neurobiology of anxious states, the current article focuses particularly upon: the multifarious and sophisticated roles of particular person modulators, usually as a perform of the particular receptor sort and neuronal substrate concerned of their actions; novel targets for the administration of hysteria issues; the affect of neurotransmitters and different brokers upon efficiency within the VCT; knowledge acquired from complementary pharmacological and genetic methods and, lastly, a number of open questions prone to orientate future experimental- and clinical-analysis.
 MUC16 Antibody |
|||
| 49090-50ul | SAB | 50ul | EUR 239 |
MUC16 Antibody |
|||
| 1-CSB-PA070303 | Cusabio |
|
|
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is Unconjugated. Tested in the following application: IF, ELISA;IF:1/200-1/1000.ELISA:1/20000 |
|||
MUC16 Antibody |
|||
| 1-CSB-PA10657A0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
MUC16 Antibody |
|||
| CSB-PA899266- | Cusabio | EUR 335 | |
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:500 |
|||
MUC16 Antibody |
|||
| CSB-PA899266-100ul | Cusabio | 100ul | EUR 316 |
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF;IF:1:100-1:500 |
|||
MUC16 Antibody |
|||
| DF7989 | Affbiotech | 200ul | EUR 304 |
|
Description: MUC16 Antibody detects endogenous levels of total MUC16. |
|||
MUC16 Antibody |
|||
| 1-CSB-PA268943 | Cusabio |
|
|
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:15-1:50 |
|||
MUC16 Antibody |
|||
| 1-CSB-PA015219GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB |
|||
MUC16 Antibody |
|||
| ABD7989 | Lifescience Market | 100 ug | EUR 438 |
 Anti-MUC16 Antibody |
|||
| A1391-100 | Biovision | EUR 370 | |
Anti-MUC16 Antibody |
|||
| A1293-100 | Biovision | EUR 370 | |
) MUC16 antibody (HRP) |
|||
| 60R-1720 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal MUC16 antibody (HRP) |
|||
) MUC16 antibody (FITC) |
|||
| 60R-1721 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal MUC16 antibody (FITC) |
|||
) MUC16 antibody (biotin) |
|||
| 60R-1722 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal MUC16 antibody (biotin) |
|||
 MUC16 Conjugated Antibody |
|||
| C49089 | SAB | 100ul | EUR 397 |
MUC16 Conjugated Antibody |
|||
| C37173 | SAB | 100ul | EUR 397 |
 MUC16,CA125 Antibody |
|||
| abx235429-100ug | Abbexa | 100 ug | EUR 551 |
MUC16,CA125 Antibody |
|||
| abx235430-100ug | Abbexa | 100 ug | EUR 509 |
 MUC16 Polyclonal Antibody |
|||
| A54125 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: The best epigenetics products |
|||
 Anti-MUC16 antibody |
|||
| STJ112045 | St John's Laboratory | 100 µl | EUR 277 |
|
Description: This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes. |
|||
 MUC16 siRNA |
|||
| 20-abx925014 | Abbexa |
|
|
 MUC16 Antibody, HRP conjugated |
|||
| 1-CSB-PA10657B0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
 MUC16 Antibody, FITC conjugated |
|||
| 1-CSB-PA10657C0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
 MUC16 Antibody, Biotin conjugated |
|||
| 1-CSB-PA10657D0Rb | Cusabio |
|
|
|
Description: A polyclonal antibody against MUC16. Recognizes MUC16 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
 Antibody) Mucin 16 (MUC16) Antibody |
|||
| abx036002-100ug | Abbexa | 100 ug | EUR 391 |
 Monoclonal MUC16 / CA125 Antibody |
|||
| AMM01977G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A Monoclonal antibody against Human MUC16 / CA125. The antibodies are raised in Mouse. This antibody is applicable in IHC-P, E |
|||
 anti- MUC16,CA125 antibody |
|||
| FNab05429 | FN Test | 100µg | EUR 585 |
|
Description: Antibody raised against MUC16,CA125 |
|||
anti- MUC16,CA125 antibody |
|||
| FNab05430 | FN Test | 100µg | EUR 548.75 |
|
Description: Antibody raised against MUC16,CA125 |
|||
 Anti-MUC16,CA125 antibody |
|||
| PAab05429 | Lifescience Market | 100 ug | EUR 412 |
 Anti-MUC16 / CA125 antibody |
|||
| STJ72209 | St John's Laboratory | 100 µg | EUR 260 |
 antibody) Anti-Muc16 (Rat) antibody |
|||
| STJ72654 | St John's Laboratory | 100 µg | EUR 260 |
 Anti-CA125 / MUC16 antibody |
|||
| STJ180025 | St John's Laboratory | 0.1 ml | EUR 221 |
Anti-CA125 / MUC16 antibody |
|||
| STJ180303 | St John's Laboratory | 0.1 ml | EUR 215 |
 MUC16 Rabbit pAb |
|||
| A10005-100ul | Abclonal | 100 ul | EUR 308 |
MUC16 Rabbit pAb |
|||
| A10005-200ul | Abclonal | 200 ul | EUR 459 |
MUC16 Rabbit pAb |
|||
| A10005-20ul | Abclonal | 20 ul | EUR 183 |
MUC16 Rabbit pAb |
|||
| A10005-50ul | Abclonal | 50 ul | EUR 223 |
 MUC16 Blocking Peptide |
|||
| DF7989-BP | Affbiotech | 1mg | EUR 195 |
MUC16 Blocking Peptide |
|||
| 20-abx162594 | Abbexa |
|
|
 MUC16 Polyclonal Antibody, HRP Conjugated |
|||
| A54126 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: kits suitable for this type of research |
|||
 MUC16 Polyclonal Antibody, FITC Conjugated |
|||
| A54127 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: fast delivery possible |
|||
 MUC16 Polyclonal Antibody, Biotin Conjugated |
|||
| A54128 | EpiGentek | 100 µg | EUR 570.55 |
|
Description: reagents widely cited |
|||
 Anti-CA125 / MUC16 Monoclonal Antibody |
|||
| M01641-1 | BosterBio | 100ug | EUR 397 |
|
Description: Rabbit Monoclonal CA125 / MUC16 Antibody. Validated in IHC and tested in Human. |
|||
) Polyclonal MUC16 / CA125 Antibody (aa13311-13360) |
|||
| APR02845G | Leading Biology | 0.05ml | EUR 484 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human MUC16 / CA125 (aa13311-13360). This antibody is tested and proven to work in the following applications: |
|||
) Polyclonal MUC16 / CA125 Antibody (C-Term) |
|||
| APG00669G | Leading Biology | 0.1mg | EUR 484 |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human MUC16 / CA125 (C-Term). This antibody is tested and proven to work in the following applications: |
|||
 Mouse Anti-Human MUC16 Monoclonal Antibody |
|||
| CAB-1878MH | Creative Diagnostics | 1mg | EUR 663 |
 Anti-MUC16/Ca125 Rabbit Monoclonal Antibody |
|||
| M01641 | BosterBio | 100ug/vial | EUR 397 |
|
Description: Rabbit Monoclonal MUC16/Ca125 Antibody. Validated in Flow Cytometry, IF, ICC, WB and tested in Human. |
|||
 Human MUC16 ELISA Kit |
|||
| ELA-E0154h | Lifescience Market | 96 Tests | EUR 824 |
 Human MUC16 shRNA Plasmid |
|||
| 20-abx964235 | Abbexa |
|
|
 Mouse MUC16 ELISA Kit |
|||
| STJ150303 | St John's Laboratory | 1 kit | EUR 412 |
|
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of CA125 in Mouse serum, plasma and other biological fluids |
|||
Human MUC16 ELISA Kit |
|||
| STJ150507 | St John's Laboratory | 1 kit | EUR 412 |
|
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of CA125 in human serum, plasma and other biological fluids |
|||
 Anti-MUC16-VC-MMAE ADC |
|||
| ADC-W-564 | Creative Biolabs | 1mg | Ask for price |
|
Description: This ADC product is comprised of an anti-MUC16 monoclonal antibody conjugated via a VC linker to MMAE |
|||
 (pORF)) MUC16 ORF Vector (Human) (pORF) |
|||
| ORF025731 | ABM | 1.0 ug DNA | Ask for price |
 (OKCD06085)) MUC16 ELISA Kit (Human) (OKCD06085) |
|||
| OKCD06085 | Aviva Systems Biology | 96 Wells | EUR 753 |
|
Description: Description of target: This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.58U/mL |
|||
 (OKEI00807)) MUC16 ELISA Kit (Rat) (OKEI00807) |
|||
| OKEI00807 | Aviva Systems Biology | 96 Wells | EUR 767 |
|
Description: Description of target: ;Species reactivity: Rat;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 4.688U/mL |
|||
 (OKWB00244)) MUC16 ELISA Kit (Mouse) (OKWB00244) |
|||
| OKWB00244 | Aviva Systems Biology | 96 Wells | EUR 572 |
|
Description: Description of target: ;Species reactivity: Mouse;Application: ;Assay info: Assay Type: Quantitative Sandwich ELISA;Sensitivity: 1.875 U/mL |
|||
 (OKBB01014)) MUC16 ELISA Kit (Human) (OKBB01014) |
|||
| OKBB01014 | Aviva Systems Biology | 96 Wells | EUR 505 |
|
Description: Description of target: CA-125, also known as mucin 16 or MUC16, is a protein that in humans is encoded by the MUC16 gene. MUC16 is a member of the mucin family glycoproteins. It is a component of the ocular surface, the respiratory tract and the female reproductive tract epithelia. Since MUC16 is highly glycosylated it creates a hydrophilic environment that acts as a lubricating barrier against foreign particles and infectious agents on the apical membrane of epithelial cells. Also, the cytoplasmic tail of MUC16 has been shown to interact with cytoskeleton by binding members of the ERM protein family. The expression of mucin 16 has been shown to be altered in dry eye, cystic fibrosis, and several types of cancers.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
|||
 (OKAN04329)) MUC16 ELISA Kit (Human) (OKAN04329) |
|||
| OKAN04329 | Aviva Systems Biology | 96 Wells | EUR 792 |
|
Description: Description of target: This gene encodes a protein that is a member of the mucin family. Mucins are high molecular weight, O-glycosylated proteins that play an important role in forming a protective mucous barrier, and are found on the apical surfaces of the epithelia. The encoded protein is a membrane-tethered mucin that contains an extracellular domain at its amino terminus, a large tandem repeat domain, and a transmembrane domain with a short cytoplasmic domain. The amino terminus is highly glycosylated, while the repeat region contains 156 amino acid repeats unit that are rich in serines, threonines, and prolines. Interspersed within the repeats are Sea urchin sperm protein Enterokinase and Agrin (SEA) modules, leucine-rich repeats and ankyrin (ANK) repeats. These regions together form the ectodomain, and there is a potential cleavage site found near an SEA module close to the transmembrane domain. This protein is thought to play a role in forming a barrier, protecting epithelial cells from pathogens. Products of this gene have been used as a marker for different cancers, with higher expression levels associated with poorer outcomes.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.58 U/mL |
|||
 Antibody) Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| abx216976-100ug | Abbexa | 100 ug | EUR 439 |
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| 20-abx113889 | Abbexa |
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| 20-abx121442 | Abbexa |
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| 20-abx135924 | Abbexa |
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| 20-abx110007 | Abbexa |
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| 20-abx013727 | Abbexa |
|
|
 Rabbit Anti-Human MUC16 monoclonal antibody, clone TO1826 |
|||
| CABT-L757 | Creative Diagnostics | 100 ul | EUR 777 |
 (OCA125/2349R) Antibody) MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNCR2349-250 | Biotium | 250uL | EUR 394 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), RPE conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNUB2349-100 | Biotium | 100uL | EUR 264 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), Concentration: 0.2mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNUB2349-50 | Biotium | 50uL | EUR 405 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), 1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNUB2349-500 | Biotium | 500uL | EUR 513 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), Concentration: 0.2mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC552349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC552349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF555 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC432349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC432349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF543 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC472349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC472349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF647 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC042349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC042349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF405S conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC052349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC052349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF405M conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC402349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC402349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| 20-abx339194 | Abbexa |
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| abx330307-100ul | Abbexa | 100 ul | EUR 425 |
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| 20-abx322829 | Abbexa |
|
|
Ovarian Cancer-Related Tumor Marker CA125 (MUC16) Antibody |
|||
| abx430563-200ul | Abbexa | 200 ul | EUR 286 |
 Antibody) Ovarian Cancer-Related Tumor Marker CA125 (Muc16) Antibody |
|||
| abx432168-200ul | Abbexa | 200 ul | EUR 286 |
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC702349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC702349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF770 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC802349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNC802349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), CF680 conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNCH2349-100 | Biotium | 100uL | EUR 233 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R) Antibody |
|||
| BNCH2349-500 | Biotium | 500uL | EUR 545 |
|
Description: Primary antibody against MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
In view of the latest proliferation of mechanisms implicated within the pathogenesis, modulation and, probably, remedy of hysteria issues, that is an opportune second to survey their practical and pathophysiological significance, and to evaluate their affect upon efficiency within the VCT and different fashions of potential anxiolytic properties.